Institutional
Atle Fund Management AB
CIK 0001381843
$309.7M
Reported AUM
39
Positions
Q1 2026
Period
2026-05-11
Filed
The Brief · Atle Fund Management AB · Q1 2026
AI · grounded in 13F
Atle Fund Management AB established a new position in JNJ worth $11.9M. The fund also opened new stakes in EW for $8.3M and TNGX for $3.6M. To fund these moves, the manager closed its position in UFPT, reducing exposure by $5.1M, and exited ACLXGBX for $2.7M.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LLY | ELI LILLY & CO | $1131.42 | 0.55% | 48.00% | 387.10% | $26.8M | 8.67% | +8,589 | +27.6% |
| 2 | MRK | MERCK & CO. INC | $120.79 | 0.44% | 58.51% | 82.35% | $22.9M | 7.40% | −161,915 | −82.7% |
| 3 | TMO | THERMO FISHER SCIENTIFIC CORP | $472.80 | -1.91% | 18.07% | -11.30% | $14.4M | 4.67% | −6,929 | −23.2% |
| 4 | ONC | BEONE MEDICINES LTD-ADR | $271.77 | 0.62% | 5.57% | -14.68% | $12.1M | 3.92% | +1,285 | +3.2% |
| 5 | JNJ | JOHNSON & JOHNSON | $232.77 | 2.02% | 53.90% | 55.59% | $11.9M | 3.86% | +92,377 | NEW |
| 6 | BBIO | BRIDGEBIO PHARMA INC | $66.96 | -0.97% | 75.06% | 26.49% | $11.9M | 3.84% | −29,933 | −21.2% |
| 7 | VRTX | VERTEX PHARMACEUTICALS INC | $446.83 | 1.15% | -0.81% | 121.66% | $11.2M | 3.61% | — | HELD |
| 8 | ABBV | ABBVIE INC | $227.23 | 1.02% | 23.60% | 135.68% | $10.4M | 3.35% | — | HELD |
| 9 | SYK | STRYKER CORPORATION | $305.66 | 1.48% | -19.61% | 18.51% | $9.6M | 3.09% | — | HELD |
| 10 | ISRG | INTUITIVE SURGICAL INC | $422.06 | 0.77% | -24.24% | 27.71% | $9.4M | 3.05% | +48,529 | +217.4% |
| 11 | IONS | IONIS PHARMACEUTICALS INC | $73.61 | -1.16% | 111.05% | 100.54% | $9.4M | 3.03% | −64,504 | −69.8% |
| 12 | MIRM | MIRUM PHARMACEUTICALS INC | $92.79 | -0.73% | 101.55% | 546.92% | $9.4M | 3.03% | +106,083 | +118.3% |
| 13 | CVS | CVS HEALTH CORP | $95.93 | 1.17% | 56.40% | 37.47% | $9.3M | 2.99% | −82,745 | −77.7% |
| 14 | RVMD | REVOLUTION MEDICINES INC | $149.23 | -4.15% | 263.18% | 421.05% | $9.1M | 2.93% | +527,061 | +584.4% |
| 15 | BSX | BOSTON SCIENTIFIC CORP | $48.55 | -0.61% | -52.44% | 6.47% | $8.8M | 2.86% | −68,250 | −62.8% |
| 16 | AMGN | AMGEN INC | $349.58 | 1.15% | 24.03% | 69.41% | $8.7M | 2.81% | — | HELD |
| 17 | EW | EDWARDS LIFESCIENCES CORP | $85.96 | -1.70% | 10.89% | -23.43% | $8.3M | 2.67% | +106,518 | NEW |
| 18 | ALKS | ALKERMES PLC | $42.80 | -1.34% | 34.97% | 65.44% | $8.2M | 2.66% | — | HELD |
| 19 | INCY | INCYTE CORP | $103.26 | 0.86% | 48.87% | 32.36% | $8.0M | 2.57% | −20,055 | −28.3% |
| 20 | NBIX | NEUROCRINE BIOSCIENCES INC | $163.68 | -0.12% | 30.70% | 75.82% | $7.9M | 2.54% | −5,111 | −5.4% |
| 21 | GILD | GILEAD SCIENCES INC | $129.16 | -0.02% | 17.90% | 125.52% | $7.2M | 2.31% | −2,829 | −5.6% |
| 22 | KRYS | KRYSTAL BIOTECH, INC | $304.57 | 1.19% | 119.80% | 415.06% | $6.8M | 2.19% | +3,726 | +11.0% |
| 23 | COR | CENCORA INC | $275.04 | 1.75% | -4.09% | 142.19% | $6.6M | 2.13% | −303 | −1.3% |
| 24 | IRTC | IRHYTHM TECHNOLOGIES INC | $110.56 | 2.27% | -26.30% | 111.47% | $6.3M | 2.02% | −15,257 | −40.6% |
| 25 | INSM | INSMED INC | $92.67 | -1.65% | 27.98% | 283.01% | $6.0M | 1.92% | +69,565 | +249.6% |
| 26 | NAMS | NEWAMSTERDAM PHARMA CO NV | $31.17 | -1.09% | 56.50% | 225.62% | $5.5M | 1.78% | −102,240 | −51.9% |
| 27 | CELC | CELCUITY INC | $88.24 | -0.05% | 576.48% | 348.12% | $5.1M | 1.66% | +99,465 | +237.8% |
| 28 | ABVX | ABIVAX SA | $101.53 | -3.24% | 1139.68% | 900.30% | $4.8M | 1.54% | — | HELD |
| 29 | CAH | CARDINAL HEALTH INC | $205.71 | 1.97% | 34.46% | 285.46% | $4.8M | 1.54% | +85,212 | +363.1% |
| 30 | IDYA | IDEAYA BIOSCIENCES INC | $29.33 | 3.68% | 30.19% | 15.47% | $4.0M | 1.30% | −66,305 | −68.0% |
| 31 | TNGX | TANGO THERAPEUTICS INC | $27.69 | 36.94% | — | — | $3.6M | 1.17% | +29,915 | NEW |
| 32 | SYRE | SPYRE THERAPEUTICS INC | $73.65 | -6.15% | — | — | $3.5M | 1.13% | +62,735 | NEW |
| 33 | IRON | DISC MEDICINE INC | $67.00 | -5.78% | — | — | $3.2M | 1.03% | +59,288 | +123.6% |
| 34 | CMPX | COMPASS THERAPEUTICS INC | $2.04 | -0.25% | — | — | $3.1M | 0.99% | −542,501 | −92.8% |
| 35 | UNH | UNIVERSAL HEALTH SERVICES INC | $399.47 | 0.76% | — | — | $2.8M | 0.90% | — | HELD |
| 36 | DXCM | DEXCOM INC | $72.86 | 0.37% | — | — | $2.6M | 0.85% | +544,610 | +1371.1% |
| 37 | BCAX | BICARA THERAPEUTICS INC | $20.00 | -2.01% | — | — | $2.3M | 0.75% | +1,058,271 | +950.3% |
| 38 | SLNO | SOLENO THERAPEUTICS INC | $53.01 | 0.00% | — | — | $2.2M | 0.71% | +27,449 | +43.8% |
| 39 | PYXS | PYXIS ONCOLOGY INC | $1.78 | 4.09% | — | — | $1.6M | 0.52% | −420,209 | −68.1% |
| 40 | UFPT | UFP Technologies Inc | $223.87 | -0.29% | — | — | — | — | −22,986 | EXITED |
| 41 | ACLXGBX | Arcellx Inc | — | — | — | — | — | — | −41,717 | EXITED |
| 42 | AUTL | Autolus Therapeutics PLC | $1.45 | -5.55% | — | — | — | — | −1,169,634 | EXITED |
| 43 | CRBP | Corbus Pharmaceuticals Holding | $7.56 | -5.62% | — | — | — | — | −107,255 | EXITED |
Source: SEC EDGAR · accession 0001381843-26-000004. 13F discloses long positions only — shorts, foreign equities, and options are excluded.